Nasdaq

Akari Therapeutics Presents Poster on Progress in Pre-Clinical Development of Long-Acting PAS-Nomacopan as a Potential Treatment for Geographic Atrophy at the 4th Annual Dry ...

Positive pre-clinical results, including an advanced high yielding manufacturing process, support the anticipated submission of an IND in 2024 to begin clinical development with Phase 1 single and ...
Nasdaq

Ipsen and Foreseen Biotechnology announce exclusive global licensing agreement for antibody-drug conjugate with first-in-class potential

Exclusive global rights secured for development, manufacture and commercialization of FS001, completing final stages of pre-clinical development with first-in-class potential FS001 targets a novel ...
GEN

Integrated Strategies to Accelerate Pre-Clinical Development of Antibody-Drug Conjugates

Antibody-drug conjugates (ADCs) hold great promise as targeted cancer therapeutics. But their complex structure poses significant development and safety challenges for biopharma. In this GEN webinar, ...
PharmaTimes

BioDuro and CTI Biotechnology form partnership to accelerate preclinical drug development

Collaboration aims to create integrated platform from discovery to IND submission BioDuro has entered a strategic partnership with CTI Biotechnology to build an integrated preclinical development ...